Stem Cells International, 2021 · DOI: https://doi.org/10.1155/2021/9230866 · Published: July 24, 2021
Spinal cord injury (SCI) results in motor and sensory dysfunction, often due to accidents or falls. Nerve repair is challenging due to the lack of self-repair mechanisms and the presence of factors inhibiting axon regeneration. Stem cells can differentiate into neural cells, replacing damaged cells and providing neurotrophic factors that support neuroprotection, immunomodulation, and axonal regeneration, which are critical for recovery. While stem cells offer therapeutic potential in SCI, a significant risk is the potential for tumor formation due to contamination by undifferentiated cells prior to transplantation.
Stem cell transplantation may offer an effective treatment for SCI due to the self-renewing and multipotential nature of these cells.
Strategies to prevent tumorigenicity, such as eliminating contaminated cells using γ-secretase inhibitors (GSI), are crucial for safe stem cell therapies.
The spinal cord microenvironment significantly influences the success of stem cell transplantation, requiring consideration of factors like inflammation and growth factor availability.